Drug results: 1
| icotinib | Icotinib is a new epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that developed and used in China for the treatment of patients with non-small cell lung cancer (NSCLC). |
|








Citing DrugCentral © 2025.
License